Oman Pharma Regulatory Updates

Pharma Product Registration in Oman: Requirements, Process & Timeline

A comprehensive guide to pharmaceutical product registration in Oman, covering MOH requirements, documentation needed, and typical timelines for approval.

Prof. Grishma RaithathaJanuary 10, 20258 min read

Pharmaceutical product registration in Oman is overseen by the Ministry of Health (MOH), which maintains a robust regulatory framework to ensure drug safety, efficacy, and quality. Understanding the registration process is essential for any company planning to enter the Oman market.

Key Registration Requirements

The Oman MOH requires a comprehensive set of documents for pharmaceutical registration. The primary submission must be in CTD (Common Technical Document) format, organized into the standard five modules covering administrative information, quality data, safety data, and efficacy data.

Essential documents include a Certificate of Pharmaceutical Product (CPP) from the country of origin, valid GMP certificates for all manufacturing sites, stability data demonstrating product shelf life, and product samples for quality testing.

Registration Process Overview

The registration process begins with a pre-submission assessment where companies or their local representatives evaluate product eligibility and identify any gaps in documentation. Following this, the formal application is submitted through the MOH online portal.

Once submitted, the application undergoes administrative review, scientific assessment, and potentially quality testing. The MOH may issue queries requiring response within specified timeframes. Upon satisfactory review, marketing authorization is granted.

Typical Timelines

Standard pharmaceutical registrations in Oman typically take 6-12 months from complete submission to approval. Factors affecting timeline include product complexity, completeness of documentation, and MOH workload. Products with existing approvals from stringent regulatory authorities may benefit from expedited review pathways.

Common Challenges

Companies often face challenges related to documentation completeness, Arabic translation requirements, and alignment with local labeling specifications. Working with experienced regulatory consultants can help navigate these challenges and avoid common pitfalls that lead to delays.

Conclusion

Successful pharmaceutical registration in Oman requires thorough preparation, understanding of local requirements, and often local expertise to navigate the regulatory landscape efficiently. GHR Medical Services provides comprehensive support throughout the registration process.

Pharma Product Registration in Oman: Requirements, Process & Timeline | GHR Medical Services